Get startedLog in
    Picture of Harvard Apparatus Regenerative Technology logo

    HRGN — Harvard Apparatus Regenerative Technology News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Biostage receives FDA orphan drug designation for Cellspan Esophageal Implant

    Picture of Harvard Apparatus Regenerative Technology logoHarvard Apparatus Regenerative Technology
    01/12/2016 12:05
    Dec 1 (Reuters) - Biostage Inc  BSTG.O : 
    * Biostage receives FDA orphan drug designation for 
cellspan esophageal implant 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nPn83TLLqa 
Further company coverage:  BSTG.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

    Recent news on Harvard Apparatus Regenerative Technology

    See all news